Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P O'Brien

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
PDA Journal of Pharmaceutical Science and Technology|May 8, 2007
Evaluation of endotoxin retention by adsorptive-based filtration mediaThomas P O'Brien, Robert Conway, Hsiao-Lin Chen, et al.
Enantiomer|July 11, 2002
Evaluation of the origins of the selectivity of polymers imprinted with a HIV protease inhibitor using infrared spectroscopy and high performance liquid chromatographyThomas P O'Brien, Nelu Grinberg, Gary Bicker, et al.
Artificial Organs|December 10, 2009
New pulsatile hydrostatic pressure bioreactor for vascular tissue-engineered constructsFaisal M Shaikh, Thomas P O'Brien, Anthony Callanan, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Privileged structure based ligands for melanocortin receptors--4,4-disubstituted piperidine derivativesSteven L Kuklish, Ryan T Backer, Karin Briner, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2006
Privileged structure based ligands for melanocortin-4 receptors--aliphatic piperazine derivativesKarin Briner, Iván Collado, Matthew J Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2005
Potent and selective MC-4 receptor agonists based on a novel disulfide scaffoldLiang Z Yan, David Flora, Patrick Edwards, et al.
Journal of Medicinal Chemistry|April 29, 2005
Discovery of a beta-MSH-derived MC-4R selective agonistJohn P Mayer, Hansen M Hsiung, David B Flora, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptorQing Shi, Paul L Ornstein, Karin Briner, et al.
Journal of Medicinal Chemistry|January 23, 2004
Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptorTimothy I Richardson, Paul L Ornstein, Karin Briner, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
PDA Journal of Pharmaceutical Science and Technology|May 8, 2007
Evaluation of endotoxin retention by adsorptive-based filtration mediaThomas P O'Brien, Robert Conway, Hsiao-Lin Chen, et al.
Enantiomer|July 11, 2002
Evaluation of the origins of the selectivity of polymers imprinted with a HIV protease inhibitor using infrared spectroscopy and high performance liquid chromatographyThomas P O'Brien, Nelu Grinberg, Gary Bicker, et al.
Artificial Organs|December 10, 2009
New pulsatile hydrostatic pressure bioreactor for vascular tissue-engineered constructsFaisal M Shaikh, Thomas P O'Brien, Anthony Callanan, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Privileged structure based ligands for melanocortin receptors--4,4-disubstituted piperidine derivativesSteven L Kuklish, Ryan T Backer, Karin Briner, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2006
Privileged structure based ligands for melanocortin-4 receptors--aliphatic piperazine derivativesKarin Briner, Iván Collado, Matthew J Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2005
Potent and selective MC-4 receptor agonists based on a novel disulfide scaffoldLiang Z Yan, David Flora, Patrick Edwards, et al.
Journal of Medicinal Chemistry|April 29, 2005
Discovery of a beta-MSH-derived MC-4R selective agonistJohn P Mayer, Hansen M Hsiung, David B Flora, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptorQing Shi, Paul L Ornstein, Karin Briner, et al.
Journal of Medicinal Chemistry|January 23, 2004
Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptorTimothy I Richardson, Paul L Ornstein, Karin Briner, et al.
Pageof 1